Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
17/5 20:25
Key PointsCormorant acquired 950,000 Dianthus Therapeutics shares in the first quarter, estimated at $55.01 million based on quarterly average prices....
|
|
|
17/5 20:25
Key PointsCormorant acquired 950,000 Dianthus Therapeutics shares in the first quarter, estimated at $55.01 million based on quarterly average prices....